ZENTALIS PHARMACEUTICALS INC's ticker is ZNTL and the CUSIP is 98943L107. A total of 117 filers reported holding ZENTALIS PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.01 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $8,182,000 | -69.4% | 377,728 | -60.2% | 0.05% | -66.9% |
| Q2 2022 | $26,699,000 | +56.7% | 950,151 | +157.3% | 0.16% | +103.9% |
| Q1 2022 | $17,041,000 | -45.1% | 369,329 | 0.0% | 0.08% | -33.6% |
| Q4 2021 | $31,046,000 | -10.0% | 369,329 | -28.7% | 0.12% | -17.7% |
| Q3 2021 | $34,500,000 | +34.4% | 517,712 | +7.3% | 0.14% | +27.0% |
| Q2 2021 | $25,672,000 | +31.5% | 482,558 | +7.2% | 0.11% | -8.3% |
| Q1 2021 | $19,526,000 | +67.1% | 450,000 | +100.0% | 0.12% | +70.4% |
| Q4 2020 | $11,687,000 | – | 225,000 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Mayo Clinic | 362,459 | $15,727,096,000 | 18.11% |
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 2,664,409 | $115,609,000 | 2.54% |
| Matrix Capital Management Company, LP | 3,821,739 | $165,825,000 | 1.92% |
| Avidity Partners Management LP | 1,263,300 | $54,815,000 | 1.51% |
| Redmile Group, LLC | 2,221,044 | $96,371,000 | 1.36% |
| Affinity Asset Advisors, LLC | 77,500 | $3,363,000 | 1.14% |
| SPHERA FUNDS MANAGEMENT LTD. | 175,140 | $7,599,000 | 0.58% |
| Eventide Asset Management | 832,000 | $36,100,000 | 0.54% |
| Integral Health Asset Management, LLC | 40,000 | $1,736,000 | 0.50% |
| VIKING GLOBAL INVESTORS LP | 2,399,284 | $104,105,000 | 0.31% |